Aura Biosciences News

Scotiabank Remains a Buy on Aura Biosciences Inc (AURA)

TipRanksMay 10 20:07

Aura Biosciences: A Strong Buy on Promising Clinical Trials and Market Potential

TipRanksMay 10 17:57

Aura Biosciences: A Strong Buy on Promising Cancer Treatments and Solid Financials

TipRanksMay 10 02:25

Aura Biosciences Reports Q1 Results

Seeking AlphaMay 10 00:18

Aura Biosciences | 10-Q: Quarterly report

Futu NewsMay 9 19:12 · Announcements

Aura Biosciences 1Q Loss/Shr 40c >AURA

Aura Biosciences 1Q Loss/Shr 40c >AURA

Dow JonesMay 9 19:06

Press Release: Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights

Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights Continued Enrollment in Global Phase 3 CoMpass Trial in Small Choroidal Melanoma and Indeterminate Lesions Ongoi

Dow JonesMay 9 19:00

Raj Parekh to Exit Board at Aura Biosciences' Meeting

TipRanksApr 16 04:22

Aura Biosciences Inc: A Buy Rating on Strong Pipeline and Financial Health

TipRanksMar 29 15:07

Analysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF), Molina Healthcare (MOH) and Aura Biosciences Inc (AURA)

TipRanksMar 28 20:40

Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)

TipRanksMar 28 18:40

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Yahoo FinanceMar 28 18:12

Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Altimmune (ALT)

TipRanksMar 28 03:40

Aura Biosciences Shares Rise Following Q4 Results

Aura Biosciences (AURA) shares were up more than 2% in recent Wednesday trading after the clinical-stage biotechnology company reported its Q4 results. Earlier, the company booked a Q4 net loss of $22

MT NewswiresMar 28 02:00

Aura Biosciences GAAP EPS of -$1.93

Seeking AlphaMar 28 01:52

Aura Biosciences: A Strong Buy on Clinical Progress and Financial Stability

TipRanksMar 28 01:05

Recap: Aura Biosciences Q4 Earnings

Aura Biosciences (NASDAQ:AURA) reported its Q4 earnings results on Wednesday, March 27, 2024 at 07:00 AM.Here's what investors need to know about the announcement.EarningsAura Biosciences beat estimat

BenzingaMar 27 21:25

Aura Biosciences Inc Files For Mixed Shelf Offering Of Up To $350M

Aura Biosciences Inc Files For Mixed Shelf Offering Of Up To $350M

BenzingaMar 27 20:18

Aura Biosciences FY 2023 EPS $(1.93) Misses $(1.82) Estimate

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(1.93) per share which missed the analyst consensus estimate of $(1.82) by 6.04 percent. This is a 1.53 percent increase over losses of $(1

BenzingaMar 27 19:14

Aura Biosciences Cash, Cash Equivalents as at Dec. 31 $226.2M>AURA

Aura Biosciences Cash, Cash Equivalents as at Dec. 31 $226.2M>AURA

Dow JonesMar 27 19:02